{
    "eid": "2-s2.0-85087357897",
    "title": "Event-free survival at 12 months is a strong surrogate endpoint for stage 1 diffuse large B cell lymphoma: a report from Nation Wide Registry Thai Lymphoma Study Group",
    "cover-date": "2020-09-18",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Hematology",
            "@code": "2720",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Oncology",
            "@code": "2730",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Cancer Research",
            "@code": "1306",
            "@abbrev": "BIOC"
        }
    ],
    "keywords": [
        "diffuse large B-cell lymphoma",
        "EFS12",
        "prognosis",
        "risk stratification",
        "Survival"
    ],
    "authors": [
        "Kitsada Wudhikarn",
        "Udomsak Bunworasate",
        "Jakrawadee Julamanee",
        "Arnuparp Lekhakula",
        "Supachai Ekwattanakit",
        "Archrob Khuhapinant",
        "Pimjai Niparuck",
        "Suporn Chuncharunee",
        "Tontanai Numbenjapon",
        "Kannadit Prayongratana",
        "Nonglak Kanitsap",
        "Somchai Wongkhantee",
        "Nisa Makruasi",
        "Peerapon Wong",
        "Lalita Norasetthada",
        "Weerasak Nawarawong",
        "Chittima Sirijerachai",
        "Kanchana Chansung",
        "Tawatchai Suwanban",
        "Pannee Praditsuktavorn",
        "Tanin Intragumtornchai"
    ],
    "citedby-count": 1,
    "ref-count": 35,
    "ref-list": [
        "Event-free survival at 24 months is a robust end point for disease-related outcome in diffuse large B-cell lymphoma treated with immunochemotherapy",
        "Early event status informs subsequent outcome in newly diagnosed follicular lymphoma",
        "Prognostic value of event-free survival at 12 and 24 months and long-term mortality for non-Hodgkin follicular lymphoma patients: a study report from the Spanish Lymphoma Oncology Group",
        "The utility of prognostic indices, early events, and histological subtypes on predicting outcomes in non-follicular indolent B-cell lymphomas",
        "Relapse risk and loss of lifetime after modern combined modality treatment of young patients with Hodgkin lymphoma: A Nordic Lymphoma Epidemiology Group Study",
        "Evaluation of the risk of relapse in classical Hodgkin lymphoma at event-free survival time points and survival comparison with the general population in British Columbia",
        "International assessment of event-free survival at 24 months and subsequent survival in peripheral T-cell lymphoma",
        "Minimal loss of lifetime for patients with diffuse large B-cell lymphoma in remission and event free 24 months after treatment: A Danish Population-Based Study",
        "Progression-free survival at 24 months (PFS24) and subsequent outcome for patients with diffuse large B-cell lymphoma (DLBCL) enrolled on randomized clinical trials",
        "Diffuse large B-cell lymphoma",
        "Excellent outcomes and lack of prognostic impact of cell of origin for localized diffuse large B-cell lymphoma in the rituximab era",
        "Stage I non-Hodgkin lymphoma: No plateau in disease-specific survival?",
        "Inferior progression-free survival for Thai patients with diffuse large B-cell lymphoma treated under Universal Coverage Scheme: the impact of rituximab inaccessability",
        "Progression-free survival at 2 years post-autologous transplant: a surrogate end point for overall survival in follicular lymphoma",
        "Progression-free survival as a surrogate end point for overall survival in first-line diffuse large B-cell lymphoma: An individual patient-level analysis of multiple randomized trials (SEAL)",
        "Progression-free survival at 24 months (PFS24) and subsequent outcome for patients with diffuse large B-cell lymphoma (DLBCL) in the real-world setting",
        "Event free survival at 24 months is a strong surrogate prognostic endpoint of peripheral T cell lymphoma",
        "CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group",
        "Limited-stage diffuse large B-cell lymphoma treated with abbreviated systemic therapy and consolidation radiotherapy: involved-field versus involved-node radiotherapy",
        "Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial",
        "Feasibility of abbreviated cycles of immunochemotherapy for completely resected limited-stage CD20+ diffuse large B-cell lymphoma (CISL 12-09)",
        "Phase II study of rituximab plus three cycles of CHOP and involved-field radiotherapy for patients with limited-stage aggressive B-cell lymphoma: Southwest Oncology Group study 0014",
        "R-CHOP 14 with or without radiotherapy in nonbulky limited-stage diffuse large B-cell lymphoma",
        "Long-term follow-up of a PET-guided approach to treatment of limited-stage diffuse large B-cell lymphoma (DLBCL) in British Columbia (BC)",
        "PET-directed therapy for patients with limited-stage diffuse large B-cell lymphoma\u2013results of Intergroup NCTN Study S1001",
        "Stage I non-Hodgkin lymphoma: difference in survival outcome by primary extranodal site of involvement",
        "A nationwide prospective multicenter study of clinical features and outcomes of non-Hodgkin lymphoma in Thailand: an analysis of 939 cases",
        "The tumour microenvironment influences survival and time to transformation in follicular lymphoma in the rituximab era",
        "Tumor microenvironment differs between germinal centre B-cell and non-germinal centre B-cell like diffuse large B-cell lymphomas and has subtype-specific prognostic impact on survival",
        "T-cell inflamed tumor microenvironment predicts favorable prognosis in primary testicular lymphoma",
        "Immune cell constitution in the tumor microenvironment predicts the outcome in diffuse large B-cell lymphoma",
        "The tumor microenvironment of DLBCL in the computational era",
        "Intrafollicular CD4+ T-cells as an independent predictor of early clinical failure in newly diagnosed follicular lymphoma",
        "Progression of disease within 24 months in follicular lymphoma is associated with reduced intratumoral immune infiltration"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60199578",
            "affilname": "Ramathibodi Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199578",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60199575",
            "affilname": "Siriraj Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199575",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Pitsanulok",
            "@id": "60022498",
            "affilname": "Naresuan University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022498",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60022464",
            "affilname": "Chulabhorn Royal Academy",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022464",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Khon Kaen",
            "@id": "60017165",
            "affilname": "Khon Kaen University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60017165",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Khon Kaen",
            "@id": "60012921",
            "affilname": "Khon Kaen Regional Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60012921",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Pathum Thani",
            "@id": "60012521",
            "affilname": "Thammasat University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60012521",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60006964",
            "affilname": "Phramongkutklao College of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006964",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Hatyai",
            "@id": "60006314",
            "affilname": "Prince of Songkla University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006314",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60005255",
            "affilname": "Rajavithi Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60005255",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Chaing Mai",
            "@id": "60000881",
            "affilname": "Chiang Mai University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60000881",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60000316",
            "affilname": "Srinakharinwirot University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60000316",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Research Unit in Translational Hematology Chulalongkorn University",
        "Mayo Clinic",
        "Parker Institute for Cancer Immunotherapy"
    ]
}